Plain-English translation of NCT07205432 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called Injection to see how safe it is and how your body responds to it. The study is designed to look at what happens when people receive either a single dose of the medication or multiple doses over a few weeks. Researchers want to understand the medication's safety, tolerability, and how it moves through your body.
Weight management is challenging for many people, and researchers are working to develop new treatment options. This trial is an important first step to determine whether this medication is safe enough and works the way scientists hope it will.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the study you join, you will either receive a single injection of the medication (or placebo) or receive multiple injections over up to 4 weeks. Throughout the trial, you'll have regular visits where researchers will check your health, take blood samples, and monitor how your body is responding. The study will last several weeks, and you'll be randomly assigned to receive either the real medication or a placebo (an inactive substance) so researchers can fairly compare results.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China